BioRestorative Therapies Ownership | Who Owns BioRestorative Therapies?

Overview RevenueFinancials Chart Transcripts

BioRestorative Therapies Ownership Summary

BioRestorative Therapies is owned by 1.55% institutional investors, 12.13% insiders, and 86.32% retail investors. Citadel advisors is the largest institutional shareholder, holding 2.65% of BRTX shares. Fidelity Extended Market Index is the top mutual fund, with 0.76% of its assets in BioRestorative Therapies shares.

BRTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	BioRestorative Therapies	1.55%	12.13%	86.32%
Sector	Healthcare Stocks	35.49%	11.78%	52.72%
Industry	Biotech Stocks	34.84%	11.71%	53.45%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Citadel advisors	238.61K	2.65%	$64.92K
Geode capital management	223.08K	2.48%	$60.70K
Ubs group	99.83K	1.11%	$27.15K
Vanguard group	88.78K	0.97%	$103.87K
Wealth alliance	40.00K	0.44%	$10.88K
Vanguard fiduciary trust	39.45K	0.44%	$10.73K
State street	32.46K	0.36%	$8.83K
Virtu financial	24.35K	0.28%	$35.00K
Morgan stanley	15.00K	0.22%	$30.45K
Us financial advisors	17.14K	0.21%	$24.51K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Us financial advisors	17.14K	0.01%	$24.51K
Virtu financial	24.35K	0.00%	$35.00K
Wealth alliance	40.00K	0.00%	$10.88K
Renaissance	-	-	-
Td waterhouse canada	3.00	-	$1.00
Susquehanna group, llp	-	-	-
Two sigma securities	-	-	-
Bank of america corp /de/	47.00	-	$95.00
Two sigma investments, lp	-	-	-
Advisor group	2.00K	-	$540.00

Top Buyers

Holder	Shares	% Assets	Change
Citadel advisors	238.61K	-	209.41K
Geode capital management	223.08K	-	165.23K
Ubs group	99.83K	-	99.83K
Vanguard fiduciary trust	39.45K	-	39.45K
Virtu financial	24.35K	0.00%	12.32K

Top Sellers

Holder	Shares	% Assets	Change
Sabby management	-	-	-168.54K
Drw securities	-	-	-46.66K
Stonex group	-	-	-37.45K
Renaissance	-	-	-20.00K
Two sigma investments, lp	-	-	-18.17K

New Positions

Holder	Shares	% Assets	Change	Value
Ubs group	99.83K	-	99.83K	$27.15K
Vanguard fiduciary trust	39.45K	-	39.45K	$10.73K
Janiczek wealth management	1.00	-	1.00	$3.00

Sold Out

Holder	Change
Citigroup	-1.00
Wells fargo & company/mn	-1.00K
Raymond james financial	-3.00K
Newman dignan & sheerar	-11.52K
Two sigma securities	-11.78K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	3	-76.92%	139,483	-57.37%	1	12.04%	3	-57.14%	-	-100.00%
Dec 31, 2025	8	-42.86%	283,020	-25.42%	3	16.47%	5	-37.50%	-	-100.00%
Sep 30, 2025	14	-	379,488	78.70%	4	73.55%	8	100.00%	1	-75.00%
Jun 30, 2025	15	7.14%	247,366	-12.25%	2	24.87%	4	-50.00%	5	400.00%
Mar 31, 2025	14	-6.67%	281,898	0.12%	3	28.06%	9	80.00%	1	-66.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Extended Market Index	194.03K	0.76%	164.51K
Vanguard Institutional Extnd Mkt Idx Tr	49.33K	0.23%	-
Spartan Extended Market Index Pool E	7.16K	0.10%	6.31K
Fidelity Total Market Index	13.40K	0.05%	-
Fidelity Series Total Market Index	8.56K	0.03%	-
NT Ext Equity Mkt Idx Fd - L	2.43K	0.03%	-
Fidelity Nasdaq Composite Index	3.86K	0.02%	-
Spartan Total Market Index Pool E	1.04K	0.01%	-
Spartan Total Market Index Pool G	3.23K	0.01%	-
NT Ext Eq Mkt Indx Fd DC Lending Tier 5	959.00	0.01%	7.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 28, 2024	Broadrick Dale	-	Sell	$1.76K
Apr 08, 2024	Silva Francisco	VP of Research and Development	Buy	$537.88
Apr 08, 2024	Silva Francisco	VP of Research and Development	Buy	$1.44K
Apr 09, 2024	Silva Francisco	VP of Research and Development	Buy	$8.25K
Feb 08, 2024	Broadrick Dale	-	Buy	$92.45K

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	3	-
2024 Q1	4	-
2023 Q4	-	2
2023 Q3	11	-
2023 Q1	11	-

BRTX Ownership FAQ

Who Owns BioRestorative Therapies?

BioRestorative Therapies shareholders are primarily institutional investors at 1.55%, followed by 12.13% insiders and 86.32% retail investors. The average institutional ownership in BioRestorative Therapies's industry, Biotech Stocks , is 34.84%, which BioRestorative Therapies falls below.

Who owns the most shares of BioRestorative Therapies?

BioRestorative Therapies’s largest shareholders are Citadel advisors (238.61K shares, 2.65%), Geode capital management (223.08K shares, 2.48%), and Ubs group (99.83K shares, 1.11%). Together, they hold 6.24% of BioRestorative Therapies’s total shares outstanding.

Does Blackrock own BioRestorative Therapies?

BlackRock is not among the top 10 institutional shareholders of BioRestorative Therapies.

Who is BioRestorative Therapies’s biggest shareholder by percentage of total assets invested?

Us financial advisors is BioRestorative Therapies’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 17.14K BioRestorative Therapies shares, valued at 24.51K$.

Who is the top mutual fund holder of BioRestorative Therapies shares?

Fidelity Extended Market Index is the top mutual fund holder of BioRestorative Therapies shares, with 0.76% of its total shares outstanding invested in 194.03K BioRestorative Therapies shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools